Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733

Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice

Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302

Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path

Buxbaum, J. D., Thinakaran, G., Koliatsos, V. E., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 266

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage

Adle‐Biassette, Chrétien, Wingertsmann, Hery, H., Ereau, Scaravilli, Tardieu, & Gray (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00167.x · Cited by 233

Prevalence of Alzheimer plaques in AIDS

Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 225

Glial Cytokines as Neuropathogenic Factors in HIV Infection

Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S., Marshak, D. R., Nelson, S. J., & Griffin, W. S. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199405000-00003 · Cited by 150

β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology

Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) · Neuroreport · doi:10.1097/00001756-199209000-00012 · Cited by 131

Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo

Masliah, E., Westland, C., Rockenstein, E. M., Abraham, C. R., Mallory, M. E., Veinberg, I., Sheldon, E., & Mucke, L. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00553-2 · Cited by 119

Axonal Damage Revealed by Accumulation of β-APP in HIV-positive Individuals without AIDS

An, S., Giometto, B., Groves, M., Miller, R. F., Beckett, A. A. J., Gray, F., Tavolato, B. F., & Scaravilli, F. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00011 · Cited by 90

Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse

Ichihara, N., Wu, J., Hua Chui, D., Yamazaki, K., Wakabayashi, T., & Kikuchi, T. (1995) · Brain Research · doi:10.1016/0006-8993(95)00729-a · Cited by 70

The lipid raft-dwelling protein US9 can be manipulated to target APP compartmentalization, APP processing, and neurodegenerative disease pathogenesis

Brandimarti, R., Hill, G. S., Geiger, J. D., & Meucci, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-15128-8 · Cited by 8

Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms

Vera, J. H., Eftychiou, N., Schürer, M., Rullmann, M., Barthel, H., Sabri, O., Gisslén, M., Zetterberg, H., Blennow, K., O’Brien, C., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002648 · Cited by 8

New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment

Angelovich, T. A., Churchill, M. J., Wright, E., & Brew, B. J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_126 · Cited by 8

Molecular Insight into the Effect of HIV-TAT Protein on Amyloid-β Peptides

Jana, A. K., Keskin, R., & Yaşar, F. (2024) · ACS Omega · doi:10.1021/acsomega.4c02643 · Cited by 6

Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients

Bai, F., Iannuzzi, F., Merlini, E., Borghi, L., Tincati, C., Trunfio, M., Bini, T., Monforte, A. D., & Marchetti, G. C. (2016) · AIDS · doi:10.1097/qad.0000000000001346 · Cited by 7

Global developments in HIV neurology

Wright, E., Thakur, K. T., Bearden, D., & Birbeck, G. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00019-0 · Cited by 7

Structural discordance in HIV-1 Vpu from brain isolate alarms amyloid fibril forming behavior- a computational perspective

Sneha, P., Panda, P. K., Gharemirshamlu, F. R., Bamdad, K., & Balaji, S. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.04.033 · Cited by 8

CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

Lobo, J. D., Moore, D. J., Bondi, M. W., Soontornniyomkij, V., Soontornniyomkij, B., Gouaux, B. D., Achim, C. L., Ellis, R. J., & Sundermann, E. E. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-021-01048-x · Cited by 9

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial

Thela, L. T., Decloedt, E. H., Zetterberg, H., Gisslén, M., Lesosky, M., Gleich, M., Koutsilieri, E., Scheller, C., Hye, A., & Joska, J. A. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01116-4 · Cited by 7

Neuropathological Findings Associated with Long-Term HAART

Anthony, I., & Bell, J. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_4 · Cited by 7

Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B

de Almeida, S. M., Tang, B., Ribeiro, C. E., Rotta, I., Vaida, F., Piovesan, M., Fernandes, M. S. B., Letendre, S. L., Potter, M., & Ellis, R. J. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001666 · Cited by 7

HIF‐1 Targeting Intervention Renders Protection From Alzheimer's‐Like Pathology in a Humanized Mice Model of HIV Infection

Ray, S., Kumar, M., Chemparathy, D. T., Dash, P. K., & Sil, S. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70191 · Cited by 6

Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis

Mu, T., Wei, J., Sun, J., Jin, J., Zhang, T., Wu, H., & Su, B. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002480 · Cited by 8

The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease

Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6

Neuropathogenesis of Central Nervous System HIV Infection

McGuire, J. L., Goodkin, K., & Douglas, S. D. (2013) · Psychiatric Annals · doi:10.3928/00485713-20130503-05 · Cited by 6

Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.

Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 6

Genetic, Biochemical and Histopathological Aspects of Familiar Alzheimer's Disease

Ortíz, G. G., Pacheco-Moisés, F. P., González-Renovato, E. D., Figuera, L. E., Macías-Islas, M. Á., Mireles-Ramírez, M. A., Flores-Alvarado, L. J., Sánchez-López, A. L., Nuño-Penilla, D. G., Velázquez-Brizuela, I. E., et al. (2015) · InTech eBooks · doi:10.5772/59809 · Cited by 5

Ausscheiden aus der Währungsunion? -- Rechtliche Fragen

Seidel, M. (2007) · Europaische zeitschrift für wirtschatsrecht, EUZW · Cited by 5

HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner

Lloreda, C. L., Chowdhury, S., Ghura, S., Alvarez-Periel, E., & Jordan‐Sciutto, K. L. (2022) · Cells · doi:10.3390/cells11192962 · Cited by 5

HIV infection of the central nervous system

Anthony, I., Peter Simmonds, K., & Bell, J. E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.013 · Cited by 5

Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV

Zaikos, T. D., Guo, H., Barrett, A., Dastgheyb, R. M., Rubin, L. H., Troncoso, J. C., & Morris, M. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf102 · Cited by 4

Interferon-induced protein IFIT3 as a molecular nexus of neuroinflammation in Alzheimer’s disease and HIV-associated neurocognitive disorders

Das, R. K., Sahoo, N., Roy, D., Nguyen, L., Rodrigo, H., Duttaroy, A. K., Fields, J. A., & Roy, U. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03713-6 · Cited by 4

Persistence of HIV-Associated Neurocognitive Disorders in the Era of Antiretroviral Therapy

Jennifer, M. L., Brigid, K., Patrick, J., & Akay, C. (2013) · InTech eBooks · doi:10.5772/52683 · Cited by 4

HIV-associated neurocognitive disorders: a changing pattern

Simioni, S., Cavassini, M. L., Annoni, J., Hirschel, B. J., & Pasquier, R. D. (2010) · Future Neurology · doi:10.2217/fnl.10.76 · Cited by 4

A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders

Levine, A. J., Soontornniyomkij, V., Masliah, E., Sinsheimer, J. S., Ji, S. S., Horvath, S., Singer, E. J., Kallianpur, A. R., & Moore, D. J. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00846-z · Cited by 4

Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART)

Merlini, E., Iannuzzi, F., Calcagno, A., Bai, F., Trunfio, M., Monforte, A. D., Bonora, S., & Marchetti, G. C. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0661-1 · Cited by 4

[Dementia complex due to HIV disease and aging].

Moulignier, A. (2007) · PubMed · Cited by 4

Lower CSF A? is Associated with HAND in HIV-Infected Adults with a Family History of Dementia

Fazeli, P. L., Moore, D. J., Franklin, D. R., Umlauf, A., Heaton, R. K., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., Sacktor, N. C., et al. (2016) · Current HIV Research · doi:10.2174/1570162x14666151221145926 · Cited by 4

Effects of Antiretroviral Therapy in the Central Nervous System: Beyond Viral Suppression

Jordan‐Sciutto, K. L. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09987-2 · Cited by 4

The Assessment of HIV-Associated Neurocognitive Disorders: New Challenges in the HAART Era

Cysique, L. A., & Brew, B. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_7 · Cited by 4

HIV ‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model

Matubatuba, S., Willemse, C., Makhathini, K. B., Smith, C., Fisher, D., & Mentor, S. (2025) · Physiological Reports · doi:10.14814/phy2.70593 · Cited by 3

Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study

Fields, J. A., Swinton, M. K., Sundermann, E. E., Scrivens, N., Vallee, K.-A. J., & Moore, D. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.981937 · Cited by 3

Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS

Levine, A. J., Singh, K. K., & Kallianpur, A. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_19 · Cited by 3

The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities

Brandimarti, R., Irollo, E., & Meucci, O. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03153-2 · Cited by 4

Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach

Ellis, R. J., Pal, S., Achim, C. L., Sundermann, E. E., Moore, D. J., Soontornniyomkij, V., & Feldman, H. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10126-w · Cited by 5

Neuroimaging Advances in Diagnosis and Differentiation of HIV, Comorbidities, and Aging in the cART Era

Nir, T. M., Haddad, E., Thompson, P. M., & Jahanshad, N. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_221 · Cited by 3

The Changing Pathology of NeuroAIDS Associated with Drug Abuse in the Era of HAART

Jeanne, E., Anthony Iain, C., & Peter Simmonds, K. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.39.48 · Cited by 3

The Impact of HAART on Advanced Brain Aging: Implications for Mitochondrial Dysfunction and APP Processing

Campos, J. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.s10-003 · Cited by 3

Neuropathology of HIV-1 Disease

Soontornniyomkij, V. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_8 · Cited by 3

Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder

Mei-juan, Y., Zhang, X., Zhang, D., Zhang, Y., Wang, J., Zhang, Y., Gu, C., Zhang, X., & Wei, L. (2025) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2024.0053 · Cited by 2

Cerebrospinal fluid markers of alzheimer’s pathology relate to aMCI among people with HIV

Lobo, J. D., Serrano, V. B., Campbell, L. M., Bell, T., Gouaux, B. D., Galasko, D. R., Letendre, S. L., Bondi, M. W., Moore, D. J., & Sundermann, E. E. (2026) · BMC Neurology · doi:10.1186/s12883-025-04585-8 · Cited by 2

Transcriptional Profile of HIV-induced Nuclear Translocation of Amyloid β in Brain Endothelial Cells

Andras, I. E., Rampersaud, E., Eum, S. Y., & Toborek, M. J. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.003 · Cited by 2

Effects of Advances in Therapy on the Neuropathology of HIV Infection

Reverse, N., & Inhibitors, T. (2005) · Cited by 2

Interactions Between Advanced Age and HIV Cognitive Impairment

Valcour, V., & McMurtray, A. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_18 · Cited by 2

14-3-3

(2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_3 · Cited by 2

Risk Factors Associated With Incident Dementia in People Living With HIV

Lee, E., Lee, Y., & Bang, J. H. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e100 · Cited by 1

Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer’s disease-like pathology: modulatory effects of CCR5 antagonists

Bhargavan, B., Annadurai, N., & Kanmogne, G. D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02197-4 · Cited by 1

Extracellular matrix, amyloid fibrils and infections. Is there a new approach to combat amyloidosis?

Asti, A. L., Negri, E., Preda, S., Patel, L., & Colombani, C. (2026) · Journal of Medical Science · doi:10.20883/medical.e1392 · Cited by 1

Gene Therapy Blueprints for NeuroAIDS

Rodriguez, H. E., Lakshmi, S., Somboonwit, C., Oxner, A. Z., Guerra, L., Addisu, A., Gutierrez, L., Sinnott, J. T., Nilofer, C., Kangueane, P., et al. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_37 · Cited by 1

In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts

Sneha, P., Shah, U., & Balaji, S. (2019) · Medical Sciences · doi:10.3390/medsci7060074 · Cited by 2

HIV–AIDS: The Neurologic and Cognitive Consequences of HIV-1 Infection

Tate, D. F., Paul, R. H., Kertesz, K., Conley, J. J., & Russell, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_22 · Cited by 1

Chronic and subacute viral infections of the CNS

Ellison, D. W., Love, S., Chimelli, L. M. C., Harding, B. N., Lowe, J. S., Vinters, H. V., Brandner, S., & Yong, W. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3515-0.00013-1 · Cited by 1

Sociodemographic Characteristics of HIV-Associated Dementia in the South Carolina Alzheimer’s Disease Registry

Brown, M. J., Miller, M. C., Bagasra, O., & Ingram, L. A. (2023) · Southern Medical Journal · doi:10.14423/smj.0000000000001607 · Cited by 1

Can Microbes Play a Role in the Pathogenesis of Alzheimer Disease?

Fong, I. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1670-2_7 · Cited by 1

HIV–AIDS: The Neurologic and Cognitive Consequences of HIV-1 Infection

Tate, D. F., Paul, R. H., Kertesz, K., Conley, J. J., & Russell, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1364-7_20 · Cited by 1

Introduction: retroviruses, DNA viruses, and prions

Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.011 · Cited by 1

Assessing the contribution of antiretroviral therapy to neuronal damage and death as a mediator of cognitive decline in HIV-associated neurocognitive disorders

Gannon, P. J. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1

Czynniki determinuje funkcjonowanie neuropsychologiczne u osób żyjących z HIV/AIDS

Szymańska, B. (2017) · Wydawnictwa Uniwersytetu Warszawskiego eBooks · doi:10.31338/uw.9788323528111.pp.137-154 · Cited by 1

Complications of HIV infection

Shevchenko, O. S., Pentrenko, V. I., Todoriko, L. D., & Pohorielova, О. О. (2019) · Tuberculosis Lung Diseases HIV Infection · doi:10.30978/tb2019-2-85 · Cited by 1

The Role of HIV-1 Proteins in Alzheimer's Disease Pathology

Giunta, B. N. (2011) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1

Proteomic investigation of blood-based biomarkers for the diagnosis of HIV-associated neurocognitive disorders

Murugan, B. D. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1

Smaller limbic structures are associated with greater immunosuppression in over 1000 HIV-infected adults across five continents: Findings from the ENIGMA-HIV Working GroupPreprint

Nir, T. M., Fouché, J., Ananworanich, J., Ances, B. M., Boban, J. M., Brew, B. J., Chang, L., Chaganti, J. R., Ching, C. R. K., Cysique, L. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/724583 · Cited by 1

HIV-1-assoziierte neurokognitive Störung

(DNAA), F. D. D. N.-A.-A., & Eggers, C. (2014) · Der Nervenarzt · doi:10.1007/s00115-014-4082-y

Neurovirological Aspects of HIV Infection in the HAART Era

Parveen, Z., Acheampong, E. A., Pomerantz, R. J., & Mukhtār, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815691.ch10

Antiretroviral Therapy and HIV-Associated Neurocognitive Disorders

Akay, C., & Kelly, L. (2011) · InTech eBooks · doi:10.5772/23080

Original Article HIV-1 Tat Contributes to Alzheimer’s Disease-like Pathology in PSAPP Mice

Giunta, B. N., Hou, H., Zhu, Y., Rrapo, E., Tian, J., Takashi, M., Singer, E. J., He, J. J., Fern, F., & Tan, J. (2009)

Neuropharmacology of HIV/AIDS

Houff, S. A., & Major, E. O. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)85019-6

Immunomodulation As A Potential Therapeutic Approach For Alzheimer’s Disease

Nikolic, W. V. (2008) · Digital Commons - University of South Florida (University of South Florida)

Additive effects of aging and HIV infection on category verbal fluency: an analysis of component processes

Iudicello, J. E. (2011) · eScholarship (California Digital Library)

Exploring microglial activation in treated HIV-infected individuals

Vera, J. H. (2014) · Spiral (Imperial College London) · doi:10.25560/25988

VIH-1 Y Alzheimer: ¿una conexión real?

González, R., Álvarez, S., & Muñoz‐Fernández, M. Á. (2012) · Revista Complutense de Ciencias Veterinarias · doi:10.5209/rev_rccv.2012.v6.n2.41087

HIV-1 Tat Protein Promotes Amyloid β Generation and Tau Phosphorylation in Rat Hippocampal Slices

Lee, E. O., Jhang, K. A., An, Y. W., Ju, W., & Chong, Y. H. (2014) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2014.44.1.102

Maladies infectieuses et maladie d’Alzheimer

Gérard, S. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_13

Amyloid Beta Accumulation in HIV-1 Infected Brain: The Role of Altered Cholesterol

Chen, X., Lü, H., & Jd, G. (2014)

Prion Diseases, HIV-1 Associated Neurocognitive Disorders, and Alzheimer’s Disease: Implications for Protein Misfolding

Giunta, B. N., Minagar, A., & Fernandez, F. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2410-3_22

Chronic HIV infection of the CNS:

Orr, C., & Brew, B. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.012

VIH-1 Y ALZHEIMER: ¿UNA CONEXIÓN REAL? HIV-1 AND ALZHEIMER: A REAL CONECTION?

Gonzalez, R. R., & Álvarez, S. (2012)

Determinação de um perfil de marcadores associados às desordens neurocognitivas em indivíduos portadores de HIV-1

de Oliveira, A. C. S. (2018) · doi:10.11606/t.99.2018.tde-20062018-091703

Role of Withaferin A as a Neuroprotectant against Beta Amyloid Induced Toxicity and associated mechanism

Tiwari, S. (2019) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc007683

PET imaging in HIV patients

Lawal, I. O., Mokoala, K. M. G., & Sathekge, M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822960-6.00037-5

HAART drugs induce oxidative stress and mitochondrial dysfunction in blood-brain barrier

Manda, K. R. (2010)

References

(2014) · ASM Press eBooks · doi:10.1128/9781555815653.refs

Neuropharmacology of HIV/AIDS

Houff, S. A., & Major, E. O. (2007) · doi:10.1002/9780470101001.hcn069

HIV-Associated Neurocognitive Disorders

Letendre, S. L., Iudicello, J. E., Ances, B. M., Marcotte, T. D., Spudich, S., & Cohen, M. A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780199392742.003.0016

BIBLIOGRAPHY

(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8

AIDS

Kaul, M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_137

Microbiological and traumatic challenges to the CNS

Kilpatrick, T. J., Ransohoff, R. M., & Wesselingh, S. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.011

Central Nervous System Disease – Natural Neuroprotective Agents as Therapeutics

Kulkarni, A. P., Kellaway, L. A., & Kotwal, G. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_895

Brief Report: Amyloid-β PET Positivity Among Cognitively Impaired People With HIV Older Than Age 60

Wilson, S., Milicic, A., Javandel, S., Yballa, C., Milanini, B., Pohl, K. M., Paul, R. H., & Valcour, V. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003686

Lactoferrin levels in cerebrospinal fluid exhibits isoform-specific associations with Alzheimer’s diseasePreprint

Zhao, F., Puerta, R., Wang, Y., Beckett, E., García‐González, P., Valero, S., Orellana, A., Sánz, P., Kautz, T. F., Cavazos, J. E., et al. (2025) · medRxiv · doi:10.1101/2025.09.24.25336349

Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease

Chandrashekar, M., Velmurugan, G., Mishra, A., & Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.016

HIV and other Retroviral Infections of the Nervous System

Peluso, M. J., & Spudich, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00044-8

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer’s potential against amyloid-beta1–42-induced neurodegeneration

Alami, M., Berrougui, H., Boumezough, K., Salih, I., Sadki, K., Laurent, B., van Tellingen, O., Bunt, T., Khalil, A., & Fülöp, T. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112161

Rôle central des glucocorticoïdes et de leurs récepteurs dans l’étiologie de la Maladie d’Alzheimer

Canet, G. (2020) · theses.fr (ABES) · doi:10.70675/c46cedbczd8bbz4a8eza301z82de5785048c

Virus Herpès Simplex de type 1 : une cible potentielle pour la prévention de la maladie d’Alzheimer ?

Linard, M. (2021) · theses.fr (ABES) · doi:10.70675/792b3731z2670z4aedza18ezcd3259857759

Effects of HIV and azidothymidine on Alzheimer’s-like pathology and amyloid beta transporters in hu-PBL-NSG mice, brain endothelial amyloid beta uptake and endothelial barrier integrity

Bhargavan, B., Annadurai, N., & Kanmogne, G. D. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00807-4

Accelerated amyloid neurodegeneration in HIV-1-infected APP-KI Alzheimer’s disease micePreprint

Bhattarai, S., Foster, E. G., Kadry, R., Lu, Y., Kumar, M., Qasim, S., Mitra, A., Pathak, H. B., Poluektova, L. Y., Gorantla, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.16.725620

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer’s DiseasePreprint

Zhao, F., Puerta, R., Wang, Y., Beckett, E., García‐González, P., Valero, S., Sánz, P., Kautz, T. F., Cavazos, J. E., Fernández, M. V., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9678397/v1 · Cited by 1

Increased Amyloidogenic Neuronal Injury in HIV‐1–infected APP‐KI Alzheimer's disease mice

Bhattarai, S., Foster, E. G., Kadry, R., Lu, Y., Kumar, M., Qasim, S., Mitra, A., Pathak, H. B., Poluektova, L. Y., Gorantla, S., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71807

Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

Achim, C. L., Adame, A., Dumaop, W., EVERALL, I. P., & Masliah, E. (2009) · eScholarship (California Digital Library)

HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition

Morgello, S., Cortes, E. P., Gensler, G. R., Meloni, G., Jacobs, M. M., Murray, J., Borukov, V., & Crary, J. F. (2021) · AIDS · doi:10.1097/qad.0000000000002893 · Cited by 16

Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain

Li, H., McLaurin, K. A., Mactutus, C. F., Likins, B., Huang, W., Chang, S. L., & Booze, R. M. (2022) · Viruses · doi:10.3390/v14061268 · Cited by 14

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

Soontornniyomkij, V., Moore, D. J., Gouaux, B. D., Soontornniyomkij, B., Tatro, E. T., Umlauf, A., Masliah, E., Levine, A. J., Singer, E. J., Vinters, H. V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a117c · Cited by 102

Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals

Mohamed, M. A., Skolasky, R. L., Zhou, Y., Ye, W., Brašić, J. R., Brown, A. M., Pardo, C. A., Barker, P. B., Wong, D. F., & Sacktor, N. C. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00836-1 · Cited by 21